Saturday October 7, 2017
|
|
09:00 – 11:00
|
Session 1- Diabetes
|
|
Chairpersons: Baruch Itzhak, Israel & Dario Rahelic, Croatia
|
09:00 – 09:30
|
Debate: Universal or specific blood glucose targets:
HbA1c <7.0 % (<53 mmol/mol) for all? |
09:00-09:15 |
Yes: Philip Home, UK
|
09:15-09:30 |
No: Mehmet Ungan, Turkey
|
09:30-09:40 |
Discussion
|
09:40 – 10:20
|
Debate: Combination therapy – what is the best after metformin?
|
09:40-09:55 |
DPP4: Maja Racic, Bosnia and Herzegovina
|
09:55-10:10 |
SGLT2: Dario Rahelic, Croatia
|
10:10-10:20 |
Discussion
|
10:20 – 11:00
|
Debate: When, how and what type of insulin for Diabetes
type II
|
10:20-10:35 |
Basal Insulin: Baruch Itzhak, Israel
|
10:35-10:50 |
Beyond basal Insulin: Xavier Cos Claramunt, Spain
|
10:50-11:00 |
Discussion
|
11:00 – 11:30
|
Coffee Break
|
11:30 – 12:30
|
Session 2 - Diabetes and Obesity
|
|
Chairperson: Xavier Cos Claramunt, Spain
|
|
Debate: Are all the GLP1 RA the same - Long acting Vs. Short acting?
|
11:30-11:50 |
Long acting: Eberhard Standl, Germany
|
11:50-12:10 |
Short acting: Katarina Lalic, Serbia
|
|
Debate: Approaches to obesity treatment - Pharmacological VS non-pharmacological
|
12:10-12:30 |
Pro: Nina Basic, Croatia
|
12:30-12:50 |
Con: Christos Lionis, Greece
|
12:50 – 13:30
|
Lunch
|
13:30 – 14:40
|
Session 3 - Challenges in COPD and Asthma
|
|
Chairperson: Ioanna Tsiligianni, Greece
|
13:30-14:10 |
Debate: The role of inhaled corticosteroids in COPD
|
13:30-13:50 |
Dual bronchodilators (with no ICS) is better in patients with sever COPD: Ioanna Tsiligianni, Greece
|
13:50-14:10 |
Triple therapy with ICS is better in patients with severe COPD: Alan Kaplan, Canada
|
14:10-14:40 |
Debate: Asthma control-management
|
14:10-14:25 |
Asthmatic patients who self manage do better: Alan Kaplan, Canada
|
14:25-14:40 |
Patients who have intensive physician involvement do better: Catarina Panaitescu, Romania
|
14:40 – 15:30
|
Session 4 - New Therapeutics in Gastroenterology- Proton Pump Inhibitors (PPI)
|
|
Chairpersons: Juan Mendive, Spain & Hanny Yeshua, Israel
|
14:30-14:45 |
Debate: PPI a friend or a threat?
|
14:45-15:00 |
A friend: Hanny Yeshua, Israel
|
15:00-15:15 |
A threat: Juan Mendive, Spain
|
15:25-15:30 |
Discussion
|
15:30 – 16:00
|
Coffee Break
|
16:00 – 17:10
|
Session 5 - Osteoporosis and Neuropathic Pain
|
16:00-16:05 |
Chairperson: Hanny Yeshua, Israel
|
|
Debate: Osteoporosis and Neuropathic Pain
|
16:05-16:20 |
Osteoporosis, Who will be screened?
Hanny Yeshua, Israel
|
16:20-16:35 |
Osteoporosis, Who needs treatment with a medication?
Blazenka Miksic, Croatia
|
16:35-16:55 |
Lecture: Combination therapy in Neuropathic pain -where is the evidence?
Hans Thulesius, Sweden
|
16:55-17:10 |
Discussion
|
17:15 – 19:00
|
Session 6- Stroke Prevention and Atrial Fibrillation
|
17:15-17:20 |
Chairperson: Richard Hobbs, UK & Davor Milicic, Croatia
|
17:30-18:00 |
Debate: Novel anticoagulant therapy versus warfarin
|
17:30-17:45 |
Yes: for every patient: Amnon Lahad, Israel
|
17:45-18:00 |
No: Warafin should be first choice: Richard Hobbs, UK
|
18:00-18:15 |
Discussion
|
18:15-18:45 |
Debate: Should we use risk assessment tools?
|
18:15-18:30 |
Yes: Davorka Vrdoljak, Croatia
|
18:30-18:45 |
No: Shlomo Vinker, Israel
|
18:45-19:00 |
Lecture: New drugs for CHF and the rule of diagnosis in primary care
Davor Milicic, Croatia
|